Altre lingue China NT Pharma Group Company Limited

Azioni

1011

KYG2114L1059

Tempo differito Hong Kong S.E. Altri mercati azionari 08:45:14 26/06/2024			Variaz. 5gg	Var. 1 gen.
0,034 ^HKD	+6,25%		+30,77%	-38,18%

07/06	Gli azionisti di China NT Pharma voteranno il 28 giugno sulla proposta di consolidamento azionario	MT
28/03	China NT Pharma Group Company Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

China NT Pharma Shareholders to Vote June 28 on Proposed Share Consolidation	07/06
China NT Pharma Group Company Limited Announces Change of Address of the Principal Place of Business and Headquarters	29/05
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
China NT Pharma Group Company Limited Announces Directorate Changes	15/01
China NT Pharma Group Company Limited Announces Change of Company Secretary, Effective 31 December 2023	29/12
China NT Pharma Group, Private Equity Fund Sign Cooperation Agreement; Shares Rise 4%	10/10/23
China NT Pharma Raises HK$13 Million from Private Placement	22/09/23
NT Pharma Seeks Nearly HK$24 Million from Share Placement	04/09/23
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
China NT Pharma Lays Out Restructuring Plan for Embattled Unit Suzhou First Pharma	27/07/23
China NT Pharma Unit Faces Lawsuits for Alleged Loan Default	02/05/23
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
China Nt Pharma Group Company Limited Announces Change of Independent Non-Executive Director and Member of Audit Committee	19/01/23
Konruns Pharma Cancels Osteoporosis Drug Agreement With NT Pharma, US-based Pfenex	20/12/22
China NT Pharma Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/08/22
China NT Pharma Group Company Limited Announces Resignation of Wu Weizhong as Executive Director and Senior Vice President	24/08/22
China NT Pharma Signs Licensing Deal with US Company for Antibody Products	15/06/22
China NT Pharma Group Company Limited Intends to Set Up A Joint Venture Company	17/05/22
China NT Pharma Group Company Limited Updates on Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021	04/04/22
China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue China NT Pharma Group Company Limited

Azioni

1011

KYG2114L1059

Altre lingue

Filtri